Swipe om te navigeren naar een ander artikel
While medical research continues to investigate the genetic basis of cancer, and personalised prevention gains momentum, little research has been conducted with the individuals who decline predictive genetic testing for cancer. We recruited individuals who had been offered genetic testing for Lynch syndrome or bi-allelic MUTYH mutations due to their participation in a large, population-based, Australia-wide colorectal cancer study. Thirty-three individuals in mutation-carrying families, unaffected by cancer, who had actively or passively declined testing at one of four decision-making points, took part in a qualitative interview about their decision. Data analysis revealed a typology of ‘decliners’: (1) uninformed about genetic testing; (2) a weak intention to undergo genetic testing; (3) conditionally declining; and (4) unconditionally declining testing. In this population we found substantial barriers to achieving the benefits promised by predictive genetic testing; a lack of knowledge of the availability of genetic testing; a lack of trust in genetic test information; a desire to see a stronger benefit from genetic testing before proceeding; and a sense that there may be more negative than positive outcomes from genetic testing. These discourses must be addressed if medical research on the genetic basis of cancer continues to be funded, and personalised prevention of cancer continues to be recommended by experts.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 21, 2397. CrossRef
Arribas-Ayllon, M., Sarangi, S., & Clarke, A. J. (2013). Genetic testing: Accounts of autonomy, responsibility and blame. London: Routledge.
Bellcross, C. A., Bedrosian, S. R., Daniels, E., Duquette, D., Hampel, H., Jasperson, K., et al. (2012). Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: Summary of a public health/clinical collaborative meeting. Genetics in Medicine, 14, 152–162. CrossRefPubMed
Breheny, N., Geelhoed, E., Goldblatt, J., Ee, H., & O’Leary, P. (2006). Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma. PublicHealth Genomics, 9, 98–106. CrossRef
Bunton, R., & Petersen, A. (2005). Genetic Governance: Health. London: Risk and Ethics in a Biotech Era.
Claes, E., Denayer, L., Evers-Kiebooms, G., Boogaerts, A., Philippe, K., Tejpar, S., et al. (2005). Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genetic Testing, 9, 54–65. CrossRefPubMed
Clinical Oncologist Society of Australia and Australian Cancer Network. (1999). Guidelines for the prevention, early detection and management of Colorectal Cancer (CRC). Canberra: National Health and Medical Research Council.
Esplen, M. J., Madlensky, L., Aronson, M., Rothenmund, H., Gallinger, S., Butler, K., et al. (2007). Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clinical Genetics, 72, 394–401. CrossRefPubMed
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. (2009). Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine, 11, 35–41. CrossRef
Featherstone, K., Atkinson, P., Bharadwaj, A., & Clarke, A. (2006). Risky relations: Family, kinship and the new genetics. Oxford: Berg.
Financial Services Council. Genetic Testing Policy. FSC Standard No. 11. December 2005. http://www.fsc.org.au/downloads/file/ FSCStandards/11S_GeneticTestingPolicy.pdf (accessed Aug 2013).
Flander, L., Speirs-Bridge, A., Rutstein, A., Niven, H., Win, A. K., Ouakrim, D. A., et al. (2014). Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing. Journal of Genetic Counseling., 23, 79–88. CrossRefPubMed
Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., & Watson, M. (2004). Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Social Science & Medicine, 59, 553–565. CrossRef
Hallowell, N., Murton, F., Statham, H., Green, J. M., & Richards, M. P. (1997). Women’s need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study. British Medical Journal, 314, 281–283. CrossRefPubMedPubMedCentral
Keller, M., Jost, R., Kadmon, M., Wüllenweber, H. P., Haunstetter, C. M., Willeke, F., et al. (2004). Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: A comparison of participants and nonparticipants in genetic counseling. Diseases of the Colon & Rectum, 47, 153–162. CrossRef
Keogh, L. A., van Vliet, C. M., Studdert, D. M., Maskiell, J. A., Macrae, F. A., St John, D. J., et al. (2009). Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? The Medical Journal of Australia, 191, 255–258. PubMed
Konrad, M. (2005). Narrating the new predictive genetics: Ethics, ethnography, and science. Cambridge: Cambridge University Press. CrossRef
Linnenbringer, E., Roberts, J. S., Hiraki, S., Cupples, L. A., & Green, R. C. (2010). I know what you told me, but this is what I think”: Perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genetics in Medicine, 12, 219–227. CrossRefPubMedPubMedCentral
Newcomb, P. A., Baron, J., Cotterchio, M., Gallinger, S., Grove, J., Haile, R., et al. (2007). Colon Cancer Family Registry: An international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiology Biomarkers & Prevention, 16, 2331–2343. CrossRef
QSR International Pty Ltd (2010). NVivo qualitative data analysis software.
Reed, K. (2009). ‘It’s them faulty genes again’: Women, men and the gendered nature of genetic responsibility in prenatal blood screening. Sociology of Health & Illness, 31, 343–359. CrossRef
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., et al. (2008). The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology, 135, 419.e411–428.e411. CrossRef
Steinberg, D. L. (1996). Languages of risk: Genetic encryptions of the female body. Women: A cultural review, 7, 259–270.
Tilburt, J. C., James, K. M., Sinicrope, P. S., Eton, D. T., Costello, B. A., Carey, J., et al. (2011). Factors influencing cancer risk perception in high risk populations: A systematic review. Hereditary Cancer in Clinical Practice, 9, 1. CrossRef
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., et al. (2004). Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. Journal of the National Cancer Institute, 96, 261–268. CrossRefPubMedPubMedCentral
Win, A. K., Dowty, J. G., Cleary, S. P., Kim, H., Buchanan, D. D., Young, J. P., et al. (2014). Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology, 146, 1208.e1205–1211.e1205. CrossRef
Win, A. K., Young, J. P., Lindor, N. M., Tucker, K. M., Ahnen, D. J., Young, G. P., et al. (2012). Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. Journal of Clinical Oncology, 30, 958–964. CrossRefPubMedPubMedCentral
- Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining
Louise A. Keogh
- Springer US